Developmental and therapeutic implications of molecular profiles of ER-positive and ER-negative breast cancers.

被引：0
作者：
Perou, CM [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
[21]   Serum proteomic profiling distinguishes estrogen receptor (ER) positive and ER negative breast cancers. [J].
Sun, M ;
Sun, M ;
Lyons-Weiler, J ;
Lokshin, AE ;
Modugno, F ;
Marks, J ;
Bigbee, WL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :23S-23S
[22]   Therapeutic strategy for ERα mutation driven-endocrine resistance in ER-positive breast cancers [J].
Kim, Jin-Ah ;
Fuqua, Suzanne A. W. .
CANCER RESEARCH, 2018, 78 (04)
[23]   ERβ mRNA expression in ERα-negative and triple-negative breast cancers. [J].
Choi, Young ;
Kim, Hadong ;
Kim, Tae-Hoon .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[24]   Neoadjuvant therapy for ER-positive breast cancers [J].
Colleoni, M. ;
Montagna, E. .
ANNALS OF ONCOLOGY, 2012, 23 :243-248
[25]   Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers [J].
Itoh, Mitsuya ;
Iwamoto, Takayuki ;
Matsuoka, Junji ;
Nogami, Tomohiro ;
Motoki, Takayuki ;
Shien, Tadahiko ;
Taira, Naruto ;
Niikura, Naoki ;
Hayashi, Naoki ;
Ohtani, Shoichiro ;
Higaki, Kenji ;
Fujiwara, Toshiyoshi ;
Doihara, Hiroyoshi ;
Symmans, W. Fraser ;
Pusztai, Lajos .
BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (02) :403-409
[26]   Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers [J].
Mitsuya Itoh ;
Takayuki Iwamoto ;
Junji Matsuoka ;
Tomohiro Nogami ;
Takayuki Motoki ;
Tadahiko Shien ;
Naruto Taira ;
Naoki Niikura ;
Naoki Hayashi ;
Shoichiro Ohtani ;
Kenji Higaki ;
Toshiyoshi Fujiwara ;
Hiroyoshi Doihara ;
W. Fraser Symmans ;
Lajos Pusztai .
Breast Cancer Research and Treatment, 2014, 143 :403-409
[27]   Significance and Therapeutic Potential of PELP1 in ER-Negative Breast Cancers [J].
Roy, S. S. ;
Chakravarty, D. ;
De, K. ;
Tekmal, R. R. ;
Sun, L. Z. ;
Vadlamudi, R. .
CANCER RESEARCH, 2010, 70
[28]   Differential genomic landscape of estrogen receptor (ER)-low versus ER-positive (ER plus ) and ER-negative (ER-) metastatic breast cancer (MBC). [J].
Challa, Sreekar ;
Zhou, Ningxuan ;
Martin, Alyssa R. ;
Li, Yvonne Y. ;
Hughes, Melissa E. ;
Cherniack, Andrew D. ;
Curigliano, Giuseppe ;
Mittendorf, Elizabeth A. ;
Lin, Nancy U. ;
Tayob, Nabihah ;
Tolaney, Sara M. ;
Garrido-Castro, Ana Christina .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (16_SUPPL)
[29]   Evaluation of the prevention by pioglitazone/metformin of ER-positive and ER-negative mammary cancers occurring in rodents on a high-fat diet [J].
Dunn, Barbara K. ;
Suen, Chen ;
Grubbs, Clinton .
CANCER RESEARCH, 2018, 78 (13)
[30]   Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer [J].
Chimge, Nyam-Osor ;
Ahmed-Alnassar, Sara ;
Frenkel, Baruch .
CELL CYCLE, 2017, 16 (04) :312-318
12345